Holdings

Atle Fund Management AB

As of Sep 30, 2026, Atle Fund Management AB reported 37 positions worth US$360M. Largest: Eli Lilly and Company, Merck & Company, Inc. and Johnson & Johnson. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Eli Lilly and Company31,202US$36.1M+1,381Sep 30, 2026
Merck & Company, Inc.169KUS$24.6M−20,370Sep 30, 2026
Johnson & Johnson91,387US$24.2M+5,962Sep 30, 2026
AbbVie Inc.91,294US$23.9M+26,969Sep 30, 2026
Thermo Fisher Scientific Inc34,410US$23.2M+6,551Sep 30, 2026
Biogen Inc.70,955US$16M+8,174Sep 30, 2026
Vertex Pharmaceuticals Incorporated28,157US$14.7M+9,026Sep 30, 2026
Revolution Medicines, Inc.66,113US$13.6M−6,964Sep 30, 2026
BeOne Medicines Ltd. Class A35,679US$13.1M+499Sep 30, 2026
CVS Health Corporation139KUS$11.9M−6,791Sep 30, 2026